Arborea and the EIC Accelerator: Algae Grown in a Solar Leaf
Microalgae such as spirulina contain protein and pigments, but producing them economically at commercial scale remains a technical challenge. Arborea, founded by Julian Melchiorri, says its BioSolar Leaf panels cultivate algae using photosynthesis and carbon dioxide. Its website describes projects in London and Moita, near Lisbon. The EIC grant beneficiary was Arboreabiofoods LDA, registered in Portugal; Arborea Ltd is a separate UK company. Public sources reviewed do not establish the corporate relationship between the two entities.
The CORDIS record lists an EU contribution of €2,348,873 to a project with a total cost of €3,355,533.75. Its final report says Arboreabiofoods completed a fully functional 100 m² demonstration facility and a field trial lasting more than 12 months. Arborea's website lists spirulina, a blue colourant and functional proteins, but product listings do not establish commercial sales. Separately, Companies House records four director appointments at Arborea Ltd ending in 2026, including Indico Capital Partners in March and three directors on 10 August; the filings do not state why.
Company file
- Beneficiary
- Arboreabiofoods LDA, Moita, Portugal (VAT PT516134787)
- UK company
- Arborea Ltd, Companies House 09468987, incorporated March 2015, active
- Founder and CEO
- Julian Melchiorri
- Website-listed products
- Ultra Pure Spirulina, Pure Blue colourant, functional proteins
- Company-described projects
- AB InBev CO₂ pilot development in Mexico; Imperial College air-purification pilot development; V&A algae chandelier
- Control (UK)
- Majority shareholder is an individual holding 50% to 75%, per Companies House
- EIC project
- Biosolar Leaf, 1 Jan 2022 to 31 Dec 2023, closed
- EIC support
- Grant-first selection; the EIC Fund lists Arborea as invested, with country shown as the Netherlands; the page does not identify the recipient legal entity or transaction terms
Where Arborea Stands Today
Arborea's website identifies locations in Moita and London and lists spirulina, blue pigment and functional proteins. It describes work with AB InBev to develop a Mexico pilot using brewing-process CO₂, and with Imperial College London to develop an urban air-purification pilot. Arborea also says its algae "chandelier", created with the V&A, is in the museum's permanent collection. These are company descriptions; the pages do not report commercial ingredient sales or pilot performance.
Companies House filings for Arborea Ltd record a share allotment in June 2024, the appointment of Indico Capital Partners as a director that month, and the end of that appointment on 27 March 2026. Three other director appointments ended on 10 August 2026. The filings do not give reasons for these changes. Arborea Ltd's latest filed accounts, for 2024, are small-company accounts and do not disclose revenue. Companies House lists one individual as holding 50% to 75% of its shares. These UK records do not establish the ownership or financial position of Arboreabiofoods LDA.
The board
Director departures at Arborea Ltd, by year
Terminations of director appointments filed at UK Companies House for Arborea Ltd, a separate UK legal entity. The relationship to Arboreabiofoods LDA was not established in sources reviewed; Companies House filings do not state why the appointments ended.
UK Companies House, Arborea Ltd filing history.
The Technology: Algae in a Leaf
Conventional microalgae cultivation uses open ponds and closed photobioreactors. Arborea describes BioSolar Leaf as a modular panel system. The CORDIS final-period report, submitted by the project beneficiary, says the validation showed higher productivity, lower cost and carbon neutrality than alternatives; it publishes no productivity, cost or carbon-accounting figures for independent comparison. The report says the project developed three food ingredients, including two intended to replace existing products and one novel ingredient.
"Accelerating the transition to sustainable food."
Arborea, company mission statementWhat the EIC Project Promised, and What CORDIS Shows
The EIC project
EU contribution: 70% of total project cost
Biosolar Leaf ran from January 2022 to December 2023. CORDIS lists EUR 2,348,873 EU contribution and EUR 3,355,533.75 total project cost; the difference is other project costs, not necessarily company cash. The award was grant first.
CORDIS project 190186816. Values in € millions.
The project ran from January 2022 to December 2023 and aimed to advance large-scale algae cultivation for food ingredients. CORDIS reports a fully functional 100 m² BioSolar Leaf demonstration facility and a field trial lasting more than 12 months. That project report documents a demonstration, not commercial-scale operation. In May 2026, Climate Solutions News reported, based on an interview with Arborea's global commercial director, that the first full-scale factory was under construction and expected to operate in 2026 or 2027. This is a company-reported timetable; current commissioning, output and sales were not established in sources reviewed as of 2 November 2026.
- A working demonstration facilityDelivered100 m², run for more than 12 months.
- Food ingredientsReported developedCORDIS says the project developed three ingredients; current product pages are listings, not proof of sales.
- Commercial-scale cultivationReported under constructionAn interview-based report in May 2026 relayed Arborea's statement that its first full-scale factory was being built, with operation expected in 2026 or 2027; no commissioning or output evidence was located.
- Published cost and productivityNot shownClaims made without figures.
What Has Happened Since the Award
The record
From a demonstration to a planned commercial plant
The EIC beneficiary was Portuguese Arboreabiofoods LDA. Arborea Ltd is a separate UK company whose relationship to the beneficiary is not established in sources reviewed; its filings record four director appointments ending in 2026.
- Mar 2015Arborea Ltd incorporatedLondon; founder and CEO Julian Melchiorri
- Jun 2021EIC Accelerator cut-offBiosolar Leaf: large-scale microalgae cultivation for food ingredients
- Jan 2022EIC project startsArboreabiofoods LDA, Moita, Portugal€2.35M grant
- Dec 2023EIC project closes100 m² facility; field trial of more than 12 months
- Jun 2024New shares, new directorShare allotment; Portuguese VC Indico Capital Partners joins the UK board
- Dec 2024Financing roundEUR 5M round led by Indico Capital Partners with Banco Português de Fomento
- Mar 2026Indico leaves the boardInvestor-director appointment ends
- May 2026Commercial plantInterview-based report says first full-scale factory is under construction; operation projected for 2026 or 2027
- Aug 2026Three appointments endCompanies House records appointment terminations; filings give no reasons
- Nov 2026EIC Fund portfolioEIC lists Arborea as invested and gives country as Netherlands; recipient entity, amount and terms not published
CORDIS, Arborea, UK Companies House, EIC Fund, ECO, Climate Solutions News.
The Money
In December 2024 Arborea announced a EUR 5 million round led by Indico Capital Partners with Banco Português de Fomento to prepare its first commercial-scale protein facility. In June 2025 founder Julian Melchiorri told AgFunder News that the plant was expected to operate in 2027, that Arborea had raised about EUR 17 million in grants and equity overall, and that it had signed joint development agreements with unnamed multinationals. A May 2026 report described the first factory as under construction and relayed a 2026/27 operating estimate. The EIC invested-companies portfolio, checked 2 November 2026, lists Arborea as an invested company and gives its country as the Netherlands; it does not identify the recipient legal entity or publish the amount, date or terms. This portfolio entry is separate from the June 2021 cut-off list, which classified Arboreabiofoods LDA's award as grant first. The portfolio entry alone does not establish that Arboreabiofoods LDA or Arborea Ltd received the investment. Arborea Ltd accounts for 2024 do not disclose revenue, and we did not locate accessible Arboreabiofoods LDA accounts or consolidated revenue figures.
What cannot be checked
Current commissioning, production output, customer sales and revenue are not established by the sources reviewed. Companies House gives no reasons for the Arborea Ltd director appointment endings. The legal and ownership relationship between Arborea Ltd and Arboreabiofoods LDA also remains unclear in the public records reviewed.
Why Europe Should Care
Europe is looking for new protein sources and natural ingredients. Algae grown in modular facilities on non-farm land could contribute to those supply chains. The EIC grant funded a Portuguese demonstration; commercial-scale production is a separate step.
What the project promised
Large-scale microalgae cultivation to disrupt the food ingredient and protein markets.
What the record shows
A 100 m² demonstration and product listings; an interview-based report says the commercial factory was under construction in May 2026. Commissioning, output and revenue were not established; four Arborea Ltd director appointments ended in 2026, with no reasons given in the filings.
The Verdict
The commercial plant remains the test
CORDIS reports that the EIC project delivered a 100 m² demonstration facility and a field trial longer than 12 months. It did not report commercial-scale operation. Arborea was reported to be building a first commercial factory by May 2026, with operation estimated for 2026 or 2027; no commissioning, output or sales evidence was located. The EIC Fund lists Arborea as an invested company but publishes no terms. UK director changes are recorded, but Companies House gives no reasons; those filings alone do not establish a cause or broader business condition.
Arborea has not been asked for comment for this article. It is based entirely on public records, company statements and EU project data, linked throughout.
Sources
- CORDIS, Biosolar Leaf fact sheet and periodic report
- UK Companies House, Arborea Ltd filing history
- Arborea, about
- Tech.eu, €5M round, December 2024 and AgFunder News, 2027 plant, June 2025
- EIC Fund invested-companies portfolio, Arborea and European Innovation Council, June 2021 cut-off list (grant first)
- Eco, December 2024 financing round and Climate Solutions News, May 2026 factory status interview
Industry
AgrifoodFood and nutrition
- Focus
- Microalgae
- Technologies
- Photobioreactors
- Keywords
- Spirulina
- Alternative protein
- Natural colourants
- Carbon dioxide utilisation